Research supported by the JKTG Foundation has been published in the journal Science Translational Medicine.
The research, Triple-negative breast cancer metastasis involves complex epithelial-mesenchymal transition dynamics and requires vimentin, includes work by Andrew Ewald, PhD, with Johns Hopkins University School of Medicine, a researcher with whom JKTG has worked on several projects.
The work highlighted in this most recent publication investigates the molecular mechanisms that cause metastasis in triple-negative breast cancer.
Learn more about Dr. Ewald’s work, as well as research from other leading breast cancer researchers, at the Foundation’s Oct. 27 symposium Moving Breast Cancer Treatments Forward. Additional details and registration can be found on the event site.
Featured news
Ted’s Take: There are no stakeholders, it’s just US
The word “stakeholder” really bothers me particularly in the healthcare space. I’m struck by a quote by Ken Burns.
“The thing that I’ve learned is that there is no ‘them.’ This is what everybody does: make a distinction about ‘them.’ It’s just ‘us’.”
Ted’s Take: The Last Tenth
In racing, we measure this in lap times often down to the second or tenths of a second. A recent racing article provoked me to think about the pursuit of “the last tenth” of a second in improvement which is typically the toughest and most difficult to attain.
Ted‘s Take: Power in Perspective – or Academia versus the Real World
There’s an old adage – them that can do – do. Them that can’t do – teach. Many institutions and academia generally rely on credentialed academicians equating credentials with mastery of a subject area.
Jayne Koskinas Ted Giovanis
Foundation for Health and Policy
PO Box 130
Highland, Maryland 20777
Media contact: 202.548.0133